PL1781292T3 - Formulacja o przedłużonym uwalnianiu 3-amino-8-(1-piperazynylo)-2H-1-benzopiran-2-onu - Google Patents
Formulacja o przedłużonym uwalnianiu 3-amino-8-(1-piperazynylo)-2H-1-benzopiran-2-onuInfo
- Publication number
- PL1781292T3 PL1781292T3 PL05761109T PL05761109T PL1781292T3 PL 1781292 T3 PL1781292 T3 PL 1781292T3 PL 05761109 T PL05761109 T PL 05761109T PL 05761109 T PL05761109 T PL 05761109T PL 1781292 T3 PL1781292 T3 PL 1781292T3
- Authority
- PL
- Poland
- Prior art keywords
- extended release
- piperazinyl
- amino
- release formulation
- disorders
- Prior art date
Links
- 238000013265 extended release Methods 0.000 title abstract 3
- 238000009472 formulation Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- AHWHLBJKIFHNIV-UHFFFAOYSA-N 3-amino-8-piperazin-1-ylchromen-2-one Chemical compound C=12OC(=O)C(N)=CC2=CC=CC=1N1CCNCC1 AHWHLBJKIFHNIV-UHFFFAOYSA-N 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000016285 Movement disease Diseases 0.000 abstract 1
- 208000027520 Somatoform disease Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 208000027753 pain disease Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58803604P | 2004-07-15 | 2004-07-15 | |
| EP04103378 | 2004-07-15 | ||
| PCT/EP2005/053341 WO2006005760A1 (en) | 2004-07-15 | 2005-07-13 | Extended release formulation of 3-amino-8-(1-piperazinyl)-2h-1benzopyran-2-one |
| EP05761109A EP1781292B1 (en) | 2004-07-15 | 2005-07-13 | Extended release formulation of 3-amino-8-(1-piperazinyl)-2h-1benzopyran-2-one |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1781292T3 true PL1781292T3 (pl) | 2011-03-31 |
Family
ID=34978928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05761109T PL1781292T3 (pl) | 2004-07-15 | 2005-07-13 | Formulacja o przedłużonym uwalnianiu 3-amino-8-(1-piperazynylo)-2H-1-benzopiran-2-onu |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1781292B1 (pl) |
| JP (1) | JP2008506668A (pl) |
| AT (1) | ATE481971T1 (pl) |
| CA (1) | CA2570096A1 (pl) |
| DE (1) | DE602005023742D1 (pl) |
| PL (1) | PL1781292T3 (pl) |
| PT (1) | PT1781292E (pl) |
| WO (1) | WO2006005760A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| CA2765033C (en) | 2009-06-12 | 2020-07-14 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
| EP2468264A1 (en) * | 2010-12-27 | 2012-06-27 | Laboratorios Liconsa, S.A. | Oral pharmaceutical tablet for controled release of mesalazine and process for obtaining it |
| GB201504986D0 (en) * | 2015-02-13 | 2015-05-06 | Johnson Matthey Plc | Oxidation catalyst for treating a natural gas emission |
| JP6983139B2 (ja) * | 2017-11-27 | 2021-12-17 | 信越化学工業株式会社 | 固形製剤用組成物並びに固形製剤及びその製造方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0650964A1 (en) * | 1993-11-02 | 1995-05-03 | Duphar International Research B.V | 1 2H-1-benzopyran-2-one-8-yl -piperazine derivatives |
| US5478572A (en) * | 1994-09-06 | 1995-12-26 | Bristol-Myers Squibb Co. | Gepirone dosage form |
| NL9401572A (nl) * | 1994-09-27 | 1996-05-01 | Avebe Coop Verkoop Prod | Zetmeelprodukten als tabletteerhulpstof, werkwijze voor het bereiden daarvan alsmede werkwijze voor het maken van tabletten. |
| GB9706089D0 (en) * | 1997-03-24 | 1997-05-14 | Scherer Ltd R P | Pharmaceutical composition |
| US6312717B1 (en) * | 1998-07-07 | 2001-11-06 | Bristol-Myers Squibb Company | Method for treatment of anxiety and depression |
-
2005
- 2005-07-13 AT AT05761109T patent/ATE481971T1/de active
- 2005-07-13 JP JP2007520835A patent/JP2008506668A/ja active Pending
- 2005-07-13 WO PCT/EP2005/053341 patent/WO2006005760A1/en not_active Ceased
- 2005-07-13 PL PL05761109T patent/PL1781292T3/pl unknown
- 2005-07-13 PT PT05761109T patent/PT1781292E/pt unknown
- 2005-07-13 EP EP05761109A patent/EP1781292B1/en not_active Expired - Lifetime
- 2005-07-13 CA CA002570096A patent/CA2570096A1/en not_active Abandoned
- 2005-07-13 DE DE602005023742T patent/DE602005023742D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1781292A1 (en) | 2007-05-09 |
| JP2008506668A (ja) | 2008-03-06 |
| DE602005023742D1 (de) | 2010-11-04 |
| CA2570096A1 (en) | 2006-01-19 |
| ATE481971T1 (de) | 2010-10-15 |
| WO2006005760A1 (en) | 2006-01-19 |
| EP1781292B1 (en) | 2010-09-22 |
| PT1781292E (pt) | 2010-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006096434A3 (en) | Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders | |
| MY178634A (en) | Topical formulation for a jak inhibitor | |
| UA90858C2 (ru) | Композиция с контролируемым высвобождением варденафила | |
| WO2008002621A3 (en) | Benzyl-substituted quinolone m1 receptor positive allosteric modulators | |
| MXPA04003666A (es) | Uso de flibanserina para tratamiento de trastornos sexuales. | |
| PL367277A1 (pl) | Sposoby wytwarzania preparatów oksymorfonu o przedłużonym uwalnianiu | |
| WO2006096439A3 (en) | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases | |
| MXPA05004247A (es) | Cromonas y derivados de cromona y usos de los mismos. | |
| TW200633980A (en) | Pyridones useful as inhibitors of kinases | |
| SG150531A1 (en) | Use of meloxicam for the treatment of respiratory diseases in pigs | |
| UA92000C2 (en) | 1-benzylindole-2-carboxamide derivatives | |
| GB0112348D0 (en) | Compounds | |
| TW200800976A (en) | New compounds for the treatment of neurological, psychiatric or pain disorders | |
| WO2007025005A3 (en) | Sustained release formulations of nalbuphine | |
| MX2009008363A (es) | Combinacion de un antagonista de receptor muscarinico y un agonista de receptor adrenergico beta 2. | |
| WO2002088100A3 (de) | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel | |
| WO2005107810A3 (en) | Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction | |
| TW200716091A (en) | New therapeutic combinations for the treatment or prevention of psychotic disorders | |
| TW200745088A (en) | Benzimidazoles useful as inhibitors of protein kinases | |
| IL179206A0 (en) | Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same | |
| PL1781292T3 (pl) | Formulacja o przedłużonym uwalnianiu 3-amino-8-(1-piperazynylo)-2H-1-benzopiran-2-onu | |
| EP2315589A4 (en) | PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A beta2-ADRENOCEPTOR AGONIST | |
| EP2323656A4 (en) | PHARMACEUTICAL PRODUCT USING A MUSCARIN RECEPTOR ANTAGONIST AND A BETA-2 ADRENOZEPTORAGONIST | |
| WO2005082413A3 (en) | Ciclesonide and glycopyrronium combination | |
| WO2009134668A3 (en) | 4-oxo-1,4-dihydroquinoline m1 receptor positive allosteric modulators |